These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16308143)

  • 1. Polycystic ovary syndrome, a pathway to type 2 diabetes.
    Sir-Petermann T
    Nutrition; 2005; 21(11-12):1160-3. PubMed ID: 16308143
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polycystic ovarian syndrome and diabetes].
    Carlsen SM; Salvesen KA; Vanky E; Fougner KJ
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2619-21. PubMed ID: 16215603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polycystic ovary syndrome: significance of insulin resistance].
    Grott S; Algenstaedt P
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2261-6. PubMed ID: 14574641
    [No Abstract]   [Full Text] [Related]  

  • 4. Type 2 diabetes and polycystic ovary syndrome.
    Legro RS
    Fertil Steril; 2006 Jul; 86 Suppl 1():S16-7. PubMed ID: 16798276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polycystic ovarian syndrome is a health risk].
    Hippeläinen M
    Duodecim; 2002; 118(10):981-3. PubMed ID: 12238006
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance to insulin and polycystic ovary syndrome].
    Ducluzeau PH; Laville M; Vidal H; Pugeat M
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S7-12. PubMed ID: 11787441
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes risk score in the diagnostic categories of polycystic ovary syndrome.
    Moran LJ; Strauss BJ; Teede HJ
    Fertil Steril; 2011 Apr; 95(5):1742-8. PubMed ID: 21316662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P; Korenman S; Davis S
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.
    Schuring AN; Schulte N; Sonntag B; Kiesel L
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):9-15. PubMed ID: 18209494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of polycystic ovarian syndrome.
    Jones AE
    Nurs Times; 2005 Jan 18-24; 101(3):40-3. PubMed ID: 15693578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case problem: dietary recommendations to combat obesity, insulin resistance, and other concerns related to polycystic ovary syndrome.
    J Am Diet Assoc; 2000 Aug; 100(8):955-7; discussion 957-60. PubMed ID: 10955058
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S; McCarthy MI; Hardy K
    Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women.
    Talbott EO; Zborowski JV; Rager JR; Kip KE; Xu X; Orchard TJ
    J Womens Health (Larchmt); 2007 Mar; 16(2):191-7. PubMed ID: 17388735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCOS and an increased risk of type 2 diabetes mellitus.
    Stapley L
    Trends Endocrinol Metab; 2001; 12(4):146. PubMed ID: 11295565
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.
    Skov V; Glintborg D; Knudsen S; Jensen T; Kruse TA; Tan Q; Brusgaard K; Beck-Nielsen H; Højlund K
    Diabetes; 2007 Sep; 56(9):2349-55. PubMed ID: 17563058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA; Hernández Marín I; Ayala AR
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA; Wickham EP; Nestler JE
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.